US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 5.430
  • +0.370+7.31%
Close Nov 27 16:00 ET
  • 5.430
  • 0.0000.00%
Post 20:01 ET
234.42MMarket Cap-2118P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
24.20%7.03M
282K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
24.20%7.03M
--282K
Cost of revenue
Gross profit
Operating expense
138.12%38.77M
151.35%33.44M
156.51%29.36M
71.40%62.41M
136.03%21.38M
16.28M
13.3M
11.45M
13.77%36.41M
9.06M
Selling and administrative expenses
263.04%9.58M
111.05%6.11M
151.72%6.88M
55.90%12.48M
111.76%4.21M
--2.64M
--2.9M
--2.73M
30.20%8.01M
--1.99M
-General and administrative expense
263.04%9.58M
111.05%6.11M
151.72%6.88M
55.90%12.48M
111.76%4.21M
--2.64M
--2.9M
--2.73M
30.20%8.01M
--1.99M
Research and development costs
113.96%29.19M
162.58%27.32M
158.02%22.48M
75.77%49.92M
142.86%17.16M
--13.64M
--10.41M
--8.71M
9.86%28.4M
--7.07M
Operating profit
-138.12%-38.77M
-151.35%-33.44M
-156.51%-29.36M
-112.38%-62.41M
-143.61%-21.38M
-16.28M
-13.3M
-11.45M
-11.53%-29.38M
-8.78M
Net non-operating interest income expense
420.84%4.32M
2,035.32%4.66M
782.30%2.69M
319.00%2.1M
189.84%742K
830K
218K
305K
25,100.00%500K
256K
Non-operating interest income
394.89%4.36M
1,678.03%4.69M
683.67%2.74M
303.89%2.28M
165.66%789K
--880K
--264K
--349K
56,400.00%565K
--297K
Non-operating interest expense
-36.00%32K
-15.22%39K
0.00%44K
187.69%187K
14.63%47K
--50K
--46K
--44K
2,066.67%65K
--41K
Other net income (expense)
-246.15%-45K
-228.57%-23K
-766.67%-26K
-511.11%-55K
-239.13%-32K
-13K
-7K
-3K
-350.00%-9K
23K
Other non- operating income (expenses)
-246.15%-45K
-228.57%-23K
-766.67%-26K
-511.11%-55K
-239.13%-32K
---13K
---7K
---3K
-350.00%-9K
--23K
Income before tax
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
Income tax
Net income
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
Net income continuous Operations
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
---15.47M
---13.09M
---11.14M
-9.65%-28.89M
---8.5M
Minority interest income
Net income attributable to the parent company
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-123.03%-34.49M
-120.02%-28.8M
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
-15.47M
-13.09M
-11.14M
-9.65%-28.89M
-8.5M
Basic earnings per share
-111.17%-0.8
-108.93%-0.67
-159.36%-1.12
-32.06%-1.4787
-53.76%-0.5063
-0.3788
-0.3207
-0.4318
-9.65%-1.1197
-0.3293
Diluted earnings per share
-111.17%-0.8
-108.93%-0.67
-159.36%-1.12
-32.06%-1.4787
-53.76%-0.5063
-0.3788
-0.3207
-0.4318
-9.65%-1.1197
-0.3293
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000024.20%7.03M282K
Operating revenue --0--0--0--0--0--0--0--024.20%7.03M--282K
Cost of revenue
Gross profit
Operating expense 138.12%38.77M151.35%33.44M156.51%29.36M71.40%62.41M136.03%21.38M16.28M13.3M11.45M13.77%36.41M9.06M
Selling and administrative expenses 263.04%9.58M111.05%6.11M151.72%6.88M55.90%12.48M111.76%4.21M--2.64M--2.9M--2.73M30.20%8.01M--1.99M
-General and administrative expense 263.04%9.58M111.05%6.11M151.72%6.88M55.90%12.48M111.76%4.21M--2.64M--2.9M--2.73M30.20%8.01M--1.99M
Research and development costs 113.96%29.19M162.58%27.32M158.02%22.48M75.77%49.92M142.86%17.16M--13.64M--10.41M--8.71M9.86%28.4M--7.07M
Operating profit -138.12%-38.77M-151.35%-33.44M-156.51%-29.36M-112.38%-62.41M-143.61%-21.38M-16.28M-13.3M-11.45M-11.53%-29.38M-8.78M
Net non-operating interest income expense 420.84%4.32M2,035.32%4.66M782.30%2.69M319.00%2.1M189.84%742K830K218K305K25,100.00%500K256K
Non-operating interest income 394.89%4.36M1,678.03%4.69M683.67%2.74M303.89%2.28M165.66%789K--880K--264K--349K56,400.00%565K--297K
Non-operating interest expense -36.00%32K-15.22%39K0.00%44K187.69%187K14.63%47K--50K--46K--44K2,066.67%65K--41K
Other net income (expense) -246.15%-45K-228.57%-23K-766.67%-26K-511.11%-55K-239.13%-32K-13K-7K-3K-350.00%-9K23K
Other non- operating income (expenses) -246.15%-45K-228.57%-23K-766.67%-26K-511.11%-55K-239.13%-32K---13K---7K---3K-350.00%-9K--23K
Income before tax -123.03%-34.49M-120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M
Income tax
Net income -123.03%-34.49M-120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M
Net income continuous Operations -123.03%-34.49M-120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M---15.47M---13.09M---11.14M-9.65%-28.89M---8.5M
Minority interest income
Net income attributable to the parent company -123.03%-34.49M-120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -123.03%-34.49M-120.02%-28.8M-139.55%-26.69M-108.93%-60.37M-143.26%-20.67M-15.47M-13.09M-11.14M-9.65%-28.89M-8.5M
Basic earnings per share -111.17%-0.8-108.93%-0.67-159.36%-1.12-32.06%-1.4787-53.76%-0.5063-0.3788-0.3207-0.4318-9.65%-1.1197-0.3293
Diluted earnings per share -111.17%-0.8-108.93%-0.67-159.36%-1.12-32.06%-1.4787-53.76%-0.5063-0.3788-0.3207-0.4318-9.65%-1.1197-0.3293
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data